ANIK — Anika Therapeutics Share News
0.000.00%
Last trade - 00:00- $191.87m
- $150.85m
- $112.82m
Anika Therapeutics Q4 revenue beats
Anika beats Q3 revenue estimates, maintains guidance
Anika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Anika Therapeutics Q2 Revenue USD 28.219 Million
Anika Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Anika Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Anika Therapeutics Q1 Revenue USD 26.168 Million
Anika Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Anika Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Anika Therapeutics Q4 Revenue USD 30.602 Million
Anika Therapeutics Inc expected to post a loss of 1 cent a share - Earnings Preview
Anika Therapeutics falls after its completes divestiture of Parcus Medical business
Anika Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Primo Medical Group Co's Exec Management Along With Others Combined To Acquire Arthrosurface From Anika Therapeutics
Brief: Anika Therapeutics Q3 Revenue USD 38.753 Million
Brief: Anika Announces Strategic Update Of Business With Sale Of Arthrosurface And Plan To Divest Parcus Medical
Anika Therapeutics Inc expected to post a loss of 1 cent a share - Earnings Preview
Anika Therapeutics Inc reports results for the quarter ended in June - Earnings Summary